SUPPORTING ORGANIZATIONS

Animal Cancer Foundation
Mission:

Animal Cancer Foundation is a 501(c) 3 organization dedicated to finding a cure for cancer by funding research in and increasing public awareness of comparative oncology, the study of naturally occurring cancers in people and pets to discover new treatments for both.

Website:
Phone:
516-595-3012
Email:
Director:
Barbara Cohen

Association of Pediatric Hematology/Oncology Nurses
Mission:

APHON’s mission is to support and advance nurses and their practice in order to optimize outcomes for children, adolescents, and young adults with cancer and blood disorders and their families.

Website:
Phone:
847-375-4724
Email:
Director:
Amy Sherwood

Bristol-Myers Squibb
Mission:

To discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Website:
Phone:
Email:
Director:

GlaxoSmithKline
Mission:

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

Website:
Phone:
Email:
Director:

KBI Biopharma
Mission:

KBI is a leading biopharmaceutical contract services company providing fully integrated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. To date, the company has served more than 300 clients around the world, including most of the top 10 pharmaceutical companies.

Website:
Phone:
919-479-9898
Email:
Director:
Joey McMahon

Leukemia & Lymphoma Society
Mission:

Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.

Website:
Phone:
888-557-7177
Email:
Director:
Dr. Gwen Nichols

Loxo Oncology
Mission:

Loxo Oncology is dedicated to developing highly selective medicines for patients with genetically defined cancers. We base our approach on two scientific trends: the increasing use of genetic testing in cancer clinical medicine and improving chemistry approaches to building highly selective inhibitors against single targets in the cancer cell. Some people develop cancers that are caused by a single inappropriate DNA change, known as “oncogenic drivers.” When a genetic test identifies a patient with an oncogenic driver, there should be a personalized medicine to address this error in the DNA that is leading to the cancer. Loxo Oncology is developing a pipeline of highly selective drugs that inhibit oncogenic drivers in cancer.

Website:
Phone:
Email:
Director:

Making Cancer Fun
Mission:

Making Cancer Fun is the go-to resource for families facing childhood cancer. It offers practical ideas, tools and tips for parents interwoven with a personal story of resiliency and hope. Additionally, each chapter contains interactive workbook pages for parents, designed to meet the individual needs of their child. Get ready for a new cancer conversation!

Website:
Phone:
201-800-4179
Email:
Director:
Tara Geraghty

National Brain Tumor Society
Mission:

National Brain Tumor Society (NBTS) unrelentingly invests in, mobilizes and unites our community to discover a cure, deliver effective treatments, and advocate for patients and care partners.

Website:
Phone:
617-924-9997
Email:
Director:
David Arons & Danielle Leach

Novartis Oncology
Mission:

Discover new ways to improve and extend people’s lives

Website:
Phone:
Email:
Director:

Y-mAbs Therapeutics
Mission:

Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.

The company has a broad and advanced product pipeline, including 2 pivotal-stage product candidates—naxitamab and omburtamab—which target tumors that express GD2 and B7-H3, respectively.

Website:
Phone:
646-885-8480
Email:
Director:
Phil Herman